Insiders bought 78K and sold 401K on the open market.
All of the selling was scheduled in advance under 10b5-1 plans.
Get an email when SER's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7 | Stephen K. Brannan Director | Bought | 1,000 | $2.03 | 2K | New | Form 4 |
| Jun 11 – 12 | Karen J Wilson Director | Bought 2 parts | 10,100 | $1.76 average | 18K | New | Form 4 |
| May 22 | Jay Venkatesan Director | Bought | 589 | $1.78 | 1K | 0.3% | Form 4 |
| May 21 – 22 | Karen J Wilson Director | Bought 2 parts | 20,000 | $1.85 average | 37K | New | Form 4 |
| May 19 | Richard Peter Marshall Director | Bought | 12,183 | $1.65 | 20K | New | Form 4 |
| Mar 23 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 6,500 | $2.86 | 19K | 100% | Form 4 |
| Mar 19 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 39,000 | $2.50 | 98K | 100% | Form 4 |
| Feb 2 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 6,500 | $3.03 | 20K | 100% | Form 4 |
| Jan 28 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 6,500 | $3.57 | 23K | 100% | Form 4 |
| Jan 22 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 2,500 | $2.95 | 7K | 100% | Form 4 |
| Jan 20 – 21 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan 2 parts | 4,000 | $3.04 average | 12K | 100% | Form 4 |
| Jan 13 – 14 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan 2 parts | 6,500 | $2.50 average | 16K | 100% | Form 4 |
| Jan 8 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 13,000 | $2.69 | 35K | 100% | Form 4 |
| Dec 23, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 4,100 | $2.60 | 11K | 100% | Form 4 |
| Dec 22, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 5,673 | $2.67 | 15K | 100% | Form 4 |
| Dec 16, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 3,227 | $2.96 | 10K | 100% | Form 4 |
| Dec 12, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 1,700 | $3.26 | 6K | 100% | Form 4 |
| Dec 11, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 3,555 | $3.24 | 12K | 100% | Form 4 |
| Dec 9, 2025 – Dec 10, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan 2 parts | 1,245 | $3.33 average | 4K | 100% | Form 4 |
| Dec 2, 2025 – Dec 3, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan 2 parts | 6,500 | $3.61 average | 23K | 100% | Form 4 |
| Nov 25, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 5,965 | $3.90 | 23K | 50% | Form 4 |
| Nov 24, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 535 | $3.94 | 2K | 100% | Form 4 |
| Nov 18, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 6,500 | $3.75 | 24K | 100% | Form 4 |
| Nov 10, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 6,500 | $4.10 | 27K | 100% | Form 4 |
| Nov 5, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 3,398 | $4.24 | 14K | 100% | Form 4 |
| Nov 4, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 3,102 | $4.40 | 14K | 100% | Form 4 |
| Oct 28, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 5,551 | $4.96 | 28K | 100% | Form 4 |
| Oct 27, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 949 | $5.19 | 5K | 100% | Form 4 |
| Oct 20, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 6,500 | $4.97 | 32K | 100% | Form 4 |
| Oct 13, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 4,326 | $5.20 | 22K | 100% | Form 4 |
| Aug 25, 2025 – Aug 26, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan 2 parts | 47,674 | $6.95 average | 331K | 100% | Form 4 |
| Aug 18, 2025 – Aug 20, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan 2 parts | 4,304 | $5.18 average | 22K | 100% | Form 4 |
| Aug 12, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 5,500 | $5.25 | 29K | 100% | Form 4 |
| Aug 4, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 5,500 | $5.17 | 28K | 100% | Form 4 |
| Jul 29, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 4,196 | $6.50 | 27K | 100% | Form 4 |
| Jul 28, 2025 | Randall Moreadith Chief Scientific Officer | SoldNo plan | 6,500 | $5.89 | 38K | 100% | Form 4 |
| Jul 21, 2025 | Randall Moreadith Chief Scientific Officer | SoldNo plan | 6,500 | $5.34 | 35K | 100% | Form 4 |
| Jul 14, 2025 | Randall Moreadith Chief Scientific Officer | SoldNo plan | 6,500 | $5.01 | 33K | 100% | Form 4 |
| Jul 7, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 6,500 | $5.67 | 37K | 100% | Form 4 |
| Jun 30, 2025 | Randall Moreadith Chief Scientific Officer | Sold10b5-1 plan | 6,500 | $5.78 | 38K | 100% | Form 4 |
- Jul 7Stephen K. BrannanDirector · bought 1,000 at $2.032KNew position
- Jun 11 – 12Karen J WilsonDirector · bought 10,100 at avg $1.7618KNew position
- May 22Jay VenkatesanDirector · bought 589 at $1.781K0.3% of stake
- May 21 – 22Karen J WilsonDirector · bought 20,000 at avg $1.8537KNew position
- May 19Richard Peter MarshallDirector · bought 12,183 at $1.6520KNew position
- Mar 2310b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at $2.8619K100% of stake
- Mar 1910b5-1 planRandall MoreadithChief Scientific Officer · sold 39,000 at $2.5098K100% of stake
- Feb 210b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at $3.0320K100% of stake
- Jan 2810b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at $3.5723K100% of stake
- Jan 2210b5-1 planRandall MoreadithChief Scientific Officer · sold 2,500 at $2.957K100% of stake
- Jan 20 – 2110b5-1 planRandall MoreadithChief Scientific Officer · sold 4,000 at avg $3.0412K100% of stake
- Jan 13 – 1410b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at avg $2.5016K100% of stake
- Jan 810b5-1 planRandall MoreadithChief Scientific Officer · sold 13,000 at $2.6935K100% of stake
- Dec 23, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 4,100 at $2.6011K100% of stake
- Dec 22, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 5,673 at $2.6715K100% of stake
- Dec 16, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 3,227 at $2.9610K100% of stake
- Dec 12, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 1,700 at $3.266K100% of stake
- Dec 11, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 3,555 at $3.2412K100% of stake
- Dec 9, 2025 – Dec 10, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 1,245 at avg $3.334K100% of stake
- Dec 2, 2025 – Dec 3, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at avg $3.6123K100% of stake
- Nov 25, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 5,965 at $3.9023K50% of stake
- Nov 24, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 535 at $3.942K100% of stake
- Nov 18, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at $3.7524K100% of stake
- Nov 10, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at $4.1027K100% of stake
- Nov 5, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 3,398 at $4.2414K100% of stake
- Nov 4, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 3,102 at $4.4014K100% of stake
- Oct 28, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 5,551 at $4.9628K100% of stake
- Oct 27, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 949 at $5.195K100% of stake
- Oct 20, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at $4.9732K100% of stake
- Oct 13, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 4,326 at $5.2022K100% of stake
- Aug 25, 2025 – Aug 26, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 47,674 at avg $6.95331K100% of stake
- Aug 18, 2025 – Aug 20, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 4,304 at avg $5.1822K100% of stake
- Aug 12, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 5,500 at $5.2529K100% of stake
- Aug 4, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 5,500 at $5.1728K100% of stake
- Jul 29, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 4,196 at $6.5027K100% of stake
- Jul 28, 2025No planRandall MoreadithChief Scientific Officer · sold 6,500 at $5.8938K100% of stake
- Jul 21, 2025No planRandall MoreadithChief Scientific Officer · sold 6,500 at $5.3435K100% of stake
- Jul 14, 2025No planRandall MoreadithChief Scientific Officer · sold 6,500 at $5.0133K100% of stake
- Jul 7, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at $5.6737K100% of stake
- Jun 30, 202510b5-1 planRandall MoreadithChief Scientific Officer · sold 6,500 at $5.7838K100% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with SER
Spot a number that looks wrong? Check it in SER's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SER
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.